Halozyme Therapeutics (HALO) EV to EBIT (2017 - 2026)
Halozyme Therapeutics' (HALO) EV to EBIT was 14.56 for Q2 2026, up 78.4% from 8.16 a year earlier and up 1.5% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) EV to EBIT (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' EV to EBIT came in at 12.61, up 141.8% year-over-year; for FY2025, it came in at 16.60, up 73.0% from FY2024.
- By year, EV to EBIT came in at 9.59 in FY2024 (-25.5%), 12.88 in FY2023 (-53.0%), 27.39 in FY2022 (+57.3%) and 17.41 in FY2021 (-54.1%).
- Five-year quarterly EV to EBIT spans a low of 8.16 in Q2 2025 and a high of 27.39 in Q4 2022.
- Year over year, EV to EBIT has now increased in each of the last three quarters, with growth averaging 8.5% over the last eight quarters.
- The high point for year-over-year EV to EBIT in five years was Q2 2026 (growth of 78.4%); the low point was Q3 2021 (a decline of 82.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 14.34 (Q1 2026), 16.60 (Q4 2025) and 10.74 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.56 |
| Mar 31, 2026 | 14.34 |
| Dec 31, 2025 | 16.60 |
| Sep 30, 2025 | 10.74 |
| Jun 30, 2025 | 8.16 |
| Mar 31, 2025 | 11.90 |
| Dec 31, 2024 | 9.59 |
| Sep 30, 2024 | 13.86 |
| Jun 30, 2024 | 15.16 |
| Mar 31, 2024 | 12.42 |
| Dec 31, 2023 | 12.88 |
| Sep 30, 2023 | 14.67 |
| Jun 30, 2023 | 14.40 |
| Mar 31, 2023 | 19.35 |
| Dec 31, 2022 | 27.39 |
| Sep 30, 2022 | 20.36 |
| Jun 30, 2022 | 24.18 |
| Mar 31, 2022 | 15.67 |
| Dec 31, 2021 | 17.41 |
| Sep 30, 2021 | 16.56 |
API Access
Halozyme Therapeutics EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();